These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 7951043

  • 1. Enhancement in gastric mucosal epidermal growth factor receptor expression by sulglycotide.
    Slomiany BL, Piotrowski J, Czajkowski A, Murty VL, Majka J, Slomiany A.
    Biochem Mol Biol Int; 1994 May; 33(2):229-34. PubMed ID: 7951043
    [Abstract] [Full Text] [Related]

  • 2. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
    Slomiany BL, Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A.
    Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
    [Abstract] [Full Text] [Related]

  • 3. Effect of GM1-ganglioside on gastric mucosal epidermal growth factor and platelet-derived growth factor receptor expression.
    Slomiany BL, Liu J, Yao P, Piotrowski J, Grabska M, Slomiany A.
    Biochem Int; 1992 Jun; 27(1):97-104. PubMed ID: 1320885
    [Abstract] [Full Text] [Related]

  • 4. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.
    Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL.
    Biochem Mol Biol Int; 1993 Aug; 30(6):1127-34. PubMed ID: 8106073
    [Abstract] [Full Text] [Related]

  • 5. Enhancement in gastric mucosal EGF and PDGF receptor expression with ulcer healing by sulglycotide.
    Piotrowski J, Majka J, Sano S, Nowak P, Murty VL, Slomiany A, Slomiany BL.
    Gen Pharmacol; 1995 Jul; 26(4):749-53. PubMed ID: 7635250
    [Abstract] [Full Text] [Related]

  • 6. Sulglycotide displays cytoprotective activity in rat gastric mucosa.
    Niada R, Mantovani M, Prino G, Omini C, Berti F.
    Int J Tissue React; 1983 Jul; 5(3):285-8. PubMed ID: 6360935
    [Abstract] [Full Text] [Related]

  • 7. Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mucosal injury by indomethacin: effect of antiulcer agents.
    Slomiany BL, Piotrowski J, Slomiany A.
    J Physiol Pharmacol; 1999 Jun; 50(2):197-210. PubMed ID: 10424717
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of gastric mucosal blood flow with sulglycotide.
    Guslandi M, Sorghi M, Tittobello A.
    Clin Ther; 1994 Jun; 16(2):141-4; discussion 140. PubMed ID: 8062309
    [Abstract] [Full Text] [Related]

  • 9. Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide.
    Slomiany BL, Piotrowski J, Slomiany A.
    Gen Pharmacol; 1999 Feb; 32(2):251-7. PubMed ID: 10188628
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of sulglycotide on human gastric mucosa exposed to taurocholic acid.
    Corinaldesi R, Zurita J, Cenedese A, Stanghellini V, Cavalli G, Paparo G, Barbara L.
    Int J Clin Pharmacol Res; 1987 Feb; 7(2):101-4. PubMed ID: 3583492
    [Abstract] [Full Text] [Related]

  • 11. Effect of sulglycotide treatment on cell kinetics alterations induced by aspirin in humans.
    Biasco G, Paganelli GM, Psilogenis M, Nazzari M, Di Febo G, Siringo S.
    Agents Actions; 1992 Feb; Spec No():C88-9. PubMed ID: 1442343
    [Abstract] [Full Text] [Related]

  • 12. Suppression of Helicobacter pylori protease activity towards growth factors by sulglycotide.
    Piotrowski J, Slomiany A, Slomiany BL.
    J Physiol Pharmacol; 1997 Sep; 48(3):345-51. PubMed ID: 9376617
    [Abstract] [Full Text] [Related]

  • 13. Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: down-regulation of nitric oxide synthase-2 and caspase-3 by sulglycotide.
    Slomiany BL, Piotrowski J, Slomiany A.
    Biochem Biophys Res Commun; 1999 Jul 22; 261(1):15-20. PubMed ID: 10405316
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
    Czajkowski A, Piotrowski J, Yotsumoto F, Slomiany A, Slomiany BL.
    Biochem Mol Biol Int; 1993 Apr 22; 29(5):965-71. PubMed ID: 8508147
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide.
    Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL.
    Gen Pharmacol; 1993 Nov 22; 24(6):1467-72. PubMed ID: 8112522
    [Abstract] [Full Text] [Related]

  • 16. Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.
    Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL.
    Gen Pharmacol; 1997 May 22; 28(5):705-8. PubMed ID: 9184806
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
    Slomiany BL, Piotrowski J, Slomiany A.
    J Physiol Pharmacol; 2000 Jun 22; 51(2):179-92. PubMed ID: 10898092
    [Abstract] [Full Text] [Related]

  • 18. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
    Coyle WJ, Sedlack RE, Nemec R, Peterson R, Duntemann T, Murphy M, Lawson JM.
    Am J Gastroenterol; 1999 Oct 22; 94(10):2885-9. PubMed ID: 10520838
    [Abstract] [Full Text] [Related]

  • 19. Effect of sulglycotide on gastric bicarbonate secretion in humans.
    Guslandi M, Nannini D, Tittobello A.
    Drugs Exp Clin Res; 1985 Oct 22; 11(10):683-5. PubMed ID: 3836855
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
    Romano M, Ricci V, Di Popolo A, Sommi P, Del Vecchio Blanco C, Bruni CB, Ventura U, Cover TL, Blaser MJ, Coffey RJ, Zarrilli R.
    J Clin Invest; 1998 Apr 15; 101(8):1604-13. PubMed ID: 9541490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.